US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Prescription Drugs Market Research Reports & Industry Analysis

RSS Feeds

Prescription Drugs Industry Research & Market Reports

  2    4  5  6  7  8  9  10  
Bone Morphogenetic Protein (BMP) Receptor Activators -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, ...  |  read more...
USD 1,250
Bradykinin Receptor B1 Antagonists -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, ...  |  read more...
USD 1,250
Brain Derived Neurotrophic Factor (BDNF) Modulators -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, ...  |  read more...
USD 1,250
Epithelial Sodium Channel (ENaC) Inhibitors -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, ...  |  read more...
USD 1,250
GABAA Agonists -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
GABAA Modulators -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
GABAB Agonists -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
GABAB Modulators -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
Sodium Dependent Glucose Transporter 1 (SGLT1) Inhibitors -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... The DelveInsight’s Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities ...  |  read more...
USD 1,250
Toll-Like Receptor 9 (TLR-9) Antagonists -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, ...  |  read more...
USD 1,250
Toll-Like Receptor Agonists -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and ...  |  read more...
USD 1,250
Toll-Like Receptor Antagonists -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and ...  |  read more...
USD 1,250
Topoisomerase Inhibitors -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
TRAIL Receptor 1 (TRAIL-R1 or Death Receptor 4 or DR4) Agonists -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... (TRAIL-R1 or Death Receptor 4 or DR4) Agonists. The DelveInsight’s Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the ...  |  read more...
USD 1,250
Trypsin Inhibitors -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
Tumor Necrosis Factor (TNF) Agonists -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, ...  |  read more...
USD 1,250
Tumor Necrosis Factor (TNF) Inhibitors -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, ...  |  read more...
USD 1,250
Pharmaceutical Market: Saudi Arabia Industry Analysis and Opportunity Assessment, 2016-2026
8/2/2016 | published by: Future Market Insights
... is expected to register a CAGR of 9.0% over the forecast period. This study demonstrates market dynamics and trends that influence the current environment and future status of the pharmaceutical market in Saudi Arabia over ...  |  read more...
USD 3,500
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Saudi Arabia
7/1/2016 | published by: GlobalData
... source of information and analysis on the healthcare, regulatory and reimbursement landscape in Saudi Arabia. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare ...  |  read more...
USD 1,995
European Healthcare EDI Market by Supplier (Distributors and Wholesalers, GPOS, Manufacturers), Purchasing Organization (Hospitals, GPOS), Transaction (Orders, Ordersp, Desadv, Recadv, Invoic), Transaction Types and Its Penetration
7/21/2016 | published by: MarketsandMarkets
... Wholesalers, GPOs, Manufacturers), By Purchasing Organization (Hospitals, GPOs), By Transaction (ORDERS, ORDERSP, DESADV, RECADV, INVOIC)] – Transaction Types and Its Penetration” EDI provides fast, secure, and easy exchange of information between healthcare organizations. These advantages ...  |  read more...
USD 5,650
Pharmaceutical Wholesalers (NORDIC) - Industry Report
8/1/2016 | published by: Plimsoll Publishing Ltd.
... A/S and ORIOLA-KD OYJ. This report includes a wealth of information on the financial trends over the past four years. Plimsoll Publishing’s latest Pharmaceutical Wholesalers (NORDIC) analysis is ideal for anyone wanting to: See the ...  |  read more...
USD 890
Pharmaceutical Manufacturers (SWEDEN) - Industry Report
8/1/2016 | published by: Plimsoll Publishing Ltd.
... RECIPHARM STRÄNGNÄS AB. This report includes a wealth of information on the financial trends over the past four years. Plimsoll Publishing’s latest Pharmaceutical Manufacturers (SWEDEN) analysis is ideal for anyone wanting to: See the market ...  |  read more...
USD 890
Pharmaceutical Wholesalers (EUROPEAN) - Industry Report
8/1/2016 | published by: Plimsoll Publishing Ltd.
... LIMITED and GILEAD SCIENCES. This report includes a wealth of information on the financial trends over the past four years. Plimsoll Publishing’s latest Pharmaceutical Wholesalers (EUROPEAN) analysis is ideal for anyone wanting to: See the ...  |  read more...
USD 1,240
Pharmaceutical Wholesalers (GLOBAL) - Industry Report
8/1/2016 | published by: Plimsoll Publishing Ltd.
... HERBALIFE LTD. and AUSTRALIAN PHARMACEUTICAL INDUSTRIES LIMITED. This report includes a wealth of information on the financial trends over the past four years. Plimsoll Publishing’s latest Pharmaceutical Wholesalers (GLOBAL) analysis is ideal for anyone wanting ...  |  read more...
USD 1,480
Manufacture of pharmaceutical products (GERMANY) - Industry Report
8/1/2016 | published by: Plimsoll Publishing Ltd.
... auf Aktien, Merz GmbH & Co. KGaA and Overlack AG. This report includes a wealth of information on the financial trends over the past four years. Plimsoll Publishing’s latest Manufacture of pharmaceutical products (GERMANY) analysis ...  |  read more...
USD 670
  2    4  5  6  7  8  9  10